Beyond the Pill: When Medicine Meets Mindset with CEO, Will Hind
Description
How can behavioral science optimize pharmaceutical practices?
Episode 042: Will Hind, CEO of Alpharmaxim Healthcare Communications, discusses the challenges and opportunities in integrating behavioral science with pharma strategies.
Find out how this can lead to better patient outcomes and more tailored healthcare solutions.
-----
Links:
*Will Hind LinkedIn
*Will Hind X
*Alpharmaxim
*Harsh Thakkar LinkedIn
*Would you rather watch the episode? Click here!
📝 Leave us a review!
🔔 Subscribe to our channel, Life Sciences 360, for more expert insights into the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.
-----
Show Notes:
(0:00 ) Introduction to Behavioral Science in Pharma
(1:33 ) Why is behavior important in pharma?
(3:09 ) Data Analysis and Behavioral Science
(6:50 ) Breaking Down Barriers with Behavioral Science
(9:44 ) The Biggest Misconception of Behavioral Sciences
(10:52 ) Research & Clinical Trials
(14:49 ) The COM-B Model and Pharma Communication
(17:52 ) Multi-stakeholder Influence on Drug Adoption
(22:33 ) Role of Behavioral Science in Omni-channel Marketing
(26:21 ) Future of Behavioral Science in Pharma
For transcripts, check out the podcast website - www.lifesciencespod.com
United States
